510(k) K770942— PHADECODE DIFFERENTIAL FACTOR XA1 ASSAY

Substantially Equivalent

Pharmaseal Div., Baxter Healthcare Corp.

Clearance details

Applicant: Pharmaseal Div., Baxter Healthcare Corp.
Product code: Code JBQ
Advisory panel: Hematology
Date received: 1977-05-24
Decision date: 1977-07-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.